Cooper March 11 Press

Gov. Roy Cooper speaks at a recent press conference.

RALEIGH — Beginning March 17, some members of Phase 4 can get their COVID-19 vaccine — a week earlier than previously announced. 

Gov. Roy Cooper announced the new start date for Phase 4 at a March 11 press conference. Previously, some people in Phase 4 could get their vaccines starting March 24. 

"This week, (North Carolina) Department of Health and Human Services officials have continued to survey providers about how they're handling the demand from group one through three, and whether they have the capacity to move forward," Cooper said.

Based on that feedback and increased COVID-19 vaccine supply, Cooper said they were able to start vaccinations for some members of Phase 4 earlier. 

NCDHHS Secretary Mandy Cohen said those who are eligible on March 17 in Phase 4 include those who have a medical condition that's put them at higher risk and people who live in certain congregate settings. The rest of Phase 4 will begin on April 7. 

Those at high risk include:

  • Asthma (moderate to severe)

  • Cancer

  • Cerebrovascular disease or history of stroke

  • Chronic kidney disease

  • Chronic Obstructive Pulmonary Disease (COPD)

  • Cystic fibrosis

  • Diabetes type 1 or 2

"This move to Group 4 is good news and it's possible because of the tireless work of our state health officials vaccine providers, federal partners, our North Carolina National Guard and emergency management, and so many others," Cooper said. "I want you to know that your work is making all the difference."

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.